Gadolinium, a contrast dye drug used to enhance MRIs, has been linked to a serious and sometimes fatal disease called nephrogenic systemic fibrosis. The skin disease affecting the kidneys is particularly dangerous for those with severe or acute kidney insufficiencies. The threat is serious enough that the FDA required a boxed warning for the drug and warned healthcare officials to screen patients carefully prior to administration of the contrast dye.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.